Research shows prevalence of Mycoplasma genitalium in up to 1% of general population in the UK

NewsGuard 100/100 Score

A new study strengthens growing evidence that Mycoplasma genitalium (MG) is a sexually transmitted infection (STI). The findings are recently published in the International Journal of Epidemiology.

Analyses of over 4500 of urine samples from Britain's third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) showed that MG was prevalent in up to 1% of the general population aged 16-44, who had reported at least one sexual partner. Prevalence was much higher in those who had reported more than four sexual partners in the past year -- 5.2% in men and 3.1% in women. Absence of the infection in over 200 16-17 year olds who had not had vaginal, anal, or oral sex provided further evidence that MG is transmitted sexually.

Over 90% of MG in men and over two-thirds of MG cases in women were in those aged 25-44 years; an age group who would not be included in STI prevention measures currently aimed at young people in Britain.

The study also analysed risk factors for MG, such as ethnicity, number of partners, and areas of deprivation. There were strong associations with risky sexual behaviours, with similar behavioural risk factors to other known STIs. The authors found that men of Black ethnicity and those living in the most deprived areas were more likely to test positive for MG.

Interestingly, the majority of participants who tested positive for MG did not report any STI symptoms in the last month. Over half of women did not report any symptoms, but among those who did, bleeding after sex was most common. Over 90% of MG positive men did not report any symptoms. Dr Pam Sonnenberg, lead author of the paper commented that: "These findings suggest that only testing those who are currently symptomatic would miss the majority of infections. However, further research is needed to understand the clinical implications of infection and possible longer-term complications. This information, together with information on resistance patterns to guide antibiotic choice, will inform recommendations on how to test for and manage MG infection."

Source:

Oxford University Press

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Microfluidic chips advance neurodegenerative disease research